Chronic Hepatitis C Infection and Parkinsonism: What’s the Link?

Expert analysis: the importance of testing in Crohn’s disease and colitis
December 6, 2018
31 Days of Workouts to Finish 2018 in Beast Mode
December 6, 2018
Show all

Chronic Hepatitis C Infection and Parkinsonism: What’s the Link?

For patients with chronic hepatitis C (CHC), there is a significantly greater risk for developing parkinsonism, however, treatment with pegylated interferon and ribavirin (PegIFN/RBV) may reduce this risk, according to results of a recent study.

For patients with chronic hepatitis C (CHC), there is a significantly greater risk for developing parkinsonism, however, treatment with pegylated interferon and ribavirin (PegIFN/RBV) may reduce this risk, according to results of a recent study.

In order to determine the association between CHC and parkinsonism, the study authors utilized the National Health Insurance Research Database in Taiwan to identify CHC patients between 2004 and 2012. “We compared patients with and without CHC, as well as patients receiving pegylated interferon and ribavirin (PegIFN/RBV) antiviral therapy to those without such therapy,” the study authors explained. A propensity score was used to match the cohorts by age, sex, and comorbidities and patients were monitored for new diagnoses of parkinsonism

Read on: Chronic Hepatitis C Infection and Parkinsonism: What's the Link?

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.